143 related articles for article (PubMed ID: 7270402)
1. Therapeutic efficacy or oral pirbuterol in severe chronic congestive heart failure: acute hemodynamic and long-term ambulatory evaluation.
Awan NA; Needham K; Evenson MK; Hermanovich J; Joye JA; DeMaria AN; Mason DT
Am Heart J; 1981 Sep; 102(3 Pt 2):555-63. PubMed ID: 7270402
[No Abstract] [Full Text] [Related]
2. Comparison of hemodynamic actions of pirbuterol and dobutamine on cardiac function in severe congestive heart failure.
Awan NA; Needham KE; Evenson MK; Mason DT
Am J Cardiol; 1981 Mar; 47(3):665-9. PubMed ID: 7468500
[No Abstract] [Full Text] [Related]
3. Pirbuterol: a new oral sympathomimetic amine for the treatment of congestive heart failure.
Sharma B; Hoback J; Francis GS; Hodges M; Asinger RW; Cohn JN; Taylor CR
Am Heart J; 1981 Sep; 102(3 Pt 2):533-41. PubMed ID: 6115572
[TBL] [Abstract][Full Text] [Related]
4. The acute hemodynamic response to pirbuterol at rest and exercise in patients with heart failure with observations on long-term response.
Uretsky BF; Seecof RM; Reddy PS
Can J Cardiol; 1986; 2(2):80-5. PubMed ID: 3085906
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic effects of oral pirbuterol in chronic severe congestive heart failure.
Awan NA; Evenson MK; Needham KE; Evans TO; Hermanovich J; Taylor CR; Amsterdam E; Mason DT
Circulation; 1981 Jan; 63(1):96-101. PubMed ID: 7438412
[TBL] [Abstract][Full Text] [Related]
6. Management of severe chronic CHF with oral pirbuterol.
Awan NA; Needham K; Evenson MK; Mason DT
Acta Med Scand Suppl; 1981; 652():155-62. PubMed ID: 6949462
[No Abstract] [Full Text] [Related]
7. Acute haemodynamic comparison of amrinone and pirbuterol in chronic heart failure. Additional effects of isosorbide dinitrate.
Bayliss J; Norell M; Canepa-Anson R; Reuben SR; Poole-Wilson PA; Sutton GC
Br Heart J; 1983 Mar; 49(3):214-21. PubMed ID: 6830658
[TBL] [Abstract][Full Text] [Related]
8. Single-dose and dose-response studies with oral pirbuterol, a new beta agonist in chronic heart failure.
Canepa-Anson R; Dawson JR; Kuan P; Warnes CA; Poole-Wilson PA; Reuben SR; Sutton GC
Am Heart J; 1981 Sep; 102(3 Pt 2):578-83. PubMed ID: 6115575
[No Abstract] [Full Text] [Related]
9. The clinical use of inotropes in cardiac failure: dopamine, dobutamine, prenalterol and pirbuterol.
Rae AP; Tweddel AC; Hutton I
Herz; 1983 Feb; 8(1):23-33. PubMed ID: 6832690
[TBL] [Abstract][Full Text] [Related]
10. Dobutamine and nitroprusside infusion in patients with severe congestive heart failure: hemodynamic improvement by discordant effects on mitral regurgitation, left atrial function, and ventricular function.
Capomolla S; Pozzoli M; Opasich C; Febo O; Riccardi G; Salvucci F; Maestri R; Sisti M; Cobelli F; Tavazzi L
Am Heart J; 1997 Dec; 134(6):1089-98. PubMed ID: 9424070
[TBL] [Abstract][Full Text] [Related]
11. Positive inotropic therapy for short-term support and long-term management of patients with congestive heart failure: hemodynamic effects and clinical efficacy of MDL 17,043.
Uretsky BF; Valdes AM; Reddy PS
Circulation; 1986 Mar; 73(3 Pt 2):III219-29. PubMed ID: 2935328
[TBL] [Abstract][Full Text] [Related]
12. [Acute and chronic effects of oral cardiotonic agent, denopamine (TA-064) in patients with heart failure].
Inden M; Yamamuro M; Murayama S; Noda E; Tanimura H; Takasaki H; Konishi T; Nakano T; Takezawa H
Kokyu To Junkan; 1986 May; 34(5):541-6. PubMed ID: 3738247
[No Abstract] [Full Text] [Related]
13. [Drug therapy of heart failure].
Follath F
Ther Umsch; 1993 Jun; 50(6):425-33. PubMed ID: 8351674
[TBL] [Abstract][Full Text] [Related]
14. Drug regimens for congestive heart failure.
Unverferth DV; Magorien RD; Leier CV
Geriatrics; 1980 Jul; 35(7):26-33. PubMed ID: 7380254
[No Abstract] [Full Text] [Related]
15. Comparative pharmacology and clinical efficacy of newer agents in treatment of heart failure.
Taylor CR; Baird JR; Blackburn KJ; Cambridge D; Constantine JW; Ghaly MS; Hayden ML; McIlhenny HM; Moore PF; Olukotun AY; Pullman LG; Salsburg DS; Saxton CA; Shevde S
Am Heart J; 1981 Sep; 102(3 Pt 2):515-32. PubMed ID: 7023221
[TBL] [Abstract][Full Text] [Related]
16. Congestive cardiomyopathy: therapeutic approach.
Chatterjee K; Stern L
Compr Ther; 1982 Jul; 8(7):25-34. PubMed ID: 7116806
[No Abstract] [Full Text] [Related]
17. Tailored therapy using dobutamine and nitroglycerin in advanced heart failure.
Drazner MH; Solomon MA; Thompson B; Yancy CW
Am J Cardiol; 1999 Oct; 84(8):941-3, A7. PubMed ID: 10532519
[TBL] [Abstract][Full Text] [Related]
18. Treatment of chronic heart failure with pirbuterol: acute haemodynamic responses.
Dawson JR; Canepa-Anson R; Kuan P; Whitaker NH; Carnie J; Warnes C; Reuben SR; Poole-Wilson PA; Sutton GC
Br Med J (Clin Res Ed); 1981 May; 282(6274):1423-6. PubMed ID: 6112039
[TBL] [Abstract][Full Text] [Related]
19. Enoximone (MDL 17,043), a phosphodiesterase inhibitor, in the treatment of advanced, unstable chronic heart failure.
Weber KT; Janicki JS; Jain MC
J Heart Transplant; 1986; 5(2):105-12. PubMed ID: 2956397
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of oral pirbuterol on myocardial oxygen metabolism and systemic hemodynamics in chronic congestive heart failure.
Rude RE; Turi Z; Brown EJ; Lorell BH; Colucci WS; Mudge GH; Taylor CR; Grossman W
Circulation; 1981 Jul; 64(1):139-45. PubMed ID: 7237712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
